Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

Adolescents with overweight or obesity and asthma taking a GLP-1 agent had less risk of asthma exacerbations compared with ...

Asthma is not commonly recognized as a dangerous disease, however, about 10 Americans die each day from it. In addition, about 440,000 hospitalizations and 1.3 million emergency room trips result from ...

Asthma, like other complex disorders, does not appear to be inherited in a simple Mendelian fashion, despite the fact that it occurs with increased frequency in first-degree relatives of asthmatics.

New research from the La Jolla Institute for Immunology has brought a novel, long-term treatment for severe asthma a step closer. Building on a decade of work, the new findings present a potential way ...

A recent study published in Frontiers in Immunology discussed how injury and abnormal repair of the airway epithelium drive chronic obstructive pulmonary disease (COPD) and asthma. Study: Mechanisms ...

CLEVELAND--Many therapeutics for asthma and other obstructive lung diseases target the β 2-adrenergic receptor (β 2 AR), a G protein-coupled receptor (GPCR) that rapidly supports airway relaxation ...

Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...

A new study by researchers at Brigham and Women’s Hospital reveals the mechanisms behind severe inflammation in asthma. The findings demonstrate that prostaglandin E2 (PGE2), a naturally occurring ...

Research collaboration: MRC Asthma UK Centre in Allergic Mechanisms of Asthma is a research collaboration whose article contributions are accrued to its participating partner institutions. Identify ...